Clumping factor B is an important virulence factor during Staphylococcus aureus skin infection and a promising vaccine target

PLoS Pathog. 2019 Apr 22;15(4):e1007713. doi: 10.1371/journal.ppat.1007713. eCollection 2019 Apr.

Abstract

Staphylococcus aureus expresses a number of cell wall-anchored proteins that mediate adhesion and invasion of host cells and tissues and promote immune evasion, consequently contributing to the virulence of this organism. The cell wall-anchored protein clumping factor B (ClfB) has previously been shown to facilitate S. aureus nasal colonization through high affinity interactions with the cornified envelope in the anterior nares. However, the role of ClfB during skin and soft tissue infection (SSTI) has never been investigated. This study reveals a novel role for ClfB during SSTIs. ClfB is crucial in determining the abscess structure and bacterial burden early in infection and this is dependent upon a specific interaction with the ligand loricrin which is expressed within the abscess tissue. Targeting ClfB using a model vaccine that induced both protective humoral and cellular responses, leads to protection during S. aureus skin infection. This study therefore identifies ClfB as an important antigen for future SSTI vaccines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adhesins, Bacterial / genetics
  • Adhesins, Bacterial / immunology
  • Adhesins, Bacterial / metabolism*
  • Animals
  • Bacterial Adhesion
  • Female
  • Membrane Proteins / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Staphylococcal Skin Infections / immunology
  • Staphylococcal Skin Infections / metabolism
  • Staphylococcal Skin Infections / microbiology*
  • Staphylococcus aureus / immunology*
  • Vaccines / administration & dosage
  • Vaccines / immunology*
  • Virulence Factors / genetics
  • Virulence Factors / immunology
  • Virulence Factors / metabolism*
  • Virulence*

Substances

  • Adhesins, Bacterial
  • Membrane Proteins
  • Vaccines
  • Virulence Factors
  • clfB protein, Staphylococcus aureus
  • loricrin

Grants and funding

This work was supported by a Science Foundation Ireland Investigator Award (15/IA/3041) to RMM and a British Skin Foundation Award (7013s) to JAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.